Division of Surgery, Assaf Harofeh Medical Center, Zerifin, Israel(1).
Division of Surgery, Assaf Harofeh Medical Center, Zerifin, Israel(1).
Int J Surg. 2014 Dec;12(12):1258-61. doi: 10.1016/j.ijsu.2014.10.006. Epub 2014 Oct 22.
Laparoscopic cholecystectomy (LC) is the gold standard treatment for gall bladder disease.
We retrospectively reviewed charts of patients who underwent LC. Four LC groups were defined: elective LC - Group I; interval LC - Group II; LC during acute cholecystitis - Group III; and LC following percutaneous cholecystostomy (PCC) - Group IV.
The study comprised 1658 patients [mean age: 51.0 years (range 17-94)]: Group I: 1221 patients (73.6%); Group II: 271 patients (16.3%); Group III: 125 patients (7.6%); Group IV: 41 patients (2.5%). The operative time was significantly different between the groups (p < 0.05). The conversion rate was highest in Group III (24.8%) and was significantly higher than all the other groups. Group II had a higher conversion rate than Group I (p < 0.05). The length of hospital stay was not significantly different between Groups I and II (1.5 and 1.96 days, respectively), and between Groups III and IV (4.46 and 4.78 days, respectively). The differences between Groups I and II, and between Groups III and IV were significant. Complication rates were significantly different between Groups I (2.2%), II (5.6%), and III (13.6%) (p < 0.05.) There were no differences between Groups III and IV and there were no significant differences in 30-day readmission rates between the groups.
The highest conversion and complication rates were encountered in patients undergoing LC during acute cholecystitis. A gradual increase of conversion and complication rates was noted between the groups of elective LC, interval LC and LC post PCC.
腹腔镜胆囊切除术(LC)是胆囊疾病的金标准治疗方法。
我们回顾性分析了接受 LC 的患者的病历。将 LC 分为四组:择期 LC-组 I;间隔 LC-组 II;急性胆囊炎时的 LC-组 III;以及经皮胆囊造口术(PCC)后的 LC-组 IV。
本研究共纳入 1658 例患者[平均年龄:51.0 岁(17-94 岁)]:组 I:1221 例(73.6%);组 II:271 例(16.3%);组 III:125 例(7.6%);组 IV:41 例(2.5%)。各组之间的手术时间存在显著差异(p<0.05)。转换率在组 III 中最高(24.8%),明显高于其他组。组 II 的转换率高于组 I(p<0.05)。组 I 和 II 之间(分别为 1.5 天和 1.96 天)以及组 III 和 IV 之间(分别为 4.46 天和 4.78 天)的住院时间无显著差异。组 I 与组 II 之间、组 III 与组 IV 之间的差异均有统计学意义。各组之间的并发症发生率存在显著差异(组 I:2.2%,组 II:5.6%,组 III:13.6%)(p<0.05)。组 III 和组 IV 之间以及各组 30 天内再入院率之间无差异。
在急性胆囊炎患者中进行 LC 时,转换率和并发症发生率最高。择期 LC、间隔 LC 和 PCC 后 LC 组之间,转换率和并发症发生率逐渐增加。